In 2004, the American Diabetes Association found that Zyprexa was more likely to cause diabetes than many other antipsychotic drugs. A big hurdle with the Zyprexa issue is Lilly's credibility over their continuous PR on how they are going to pay out $1.2 billion . As long as they keep up this rhetoric and don't actually pay the issue won't go away. They need to think about 'putting their money where their mouth is'. -------- Daniel Haszard www.zyprexa-victims.com